Page last updated: 2024-09-04

beta-lactams and Infections, Legionella pneumophila

beta-lactams has been researched along with Infections, Legionella pneumophila in 9 studies

Research

Studies (9)

Timeframe	Studies, this research(%)	All Research%
pre-1990	1 (11.11)	18.7374
1990's	0 (0.00)	18.2507
2000's	2 (22.22)	29.6817
2010's	5 (55.56)	24.3611
2020's	1 (11.11)	2.80

Authors

Authors	Studies
Delamaire, F; Gacouin, A; Guillot, P; Lesouhaitier, M; Maamar, A; Painvin, B; Piau, C; Reizine, F; Tadié, JM	1
Arnold, C; Bassetti, S; Piso, RJ	1
Fine, MJ; Lee, JS	1
Carballo, S; Chuard, C; Eich, G; Garin, N; Genné, D; Harbarth, S; Hugli, O; Lamy, O; Nendaz, M; Perneger, T; Perrier, A; Petignat, PA; Rutschmann, O; Seravalli, L	1
Mandell, LA; Waterer, GW	1
File, TM	1
Chiner, E; Ferrufino, E; Mejía, C; Ortiz de la Tabla, V	1
Bornand, JE; Fonseca, S; Garbino, J; Sax, H; Uçkay, I	1
Fu, KP; Neu, HC	1

Trials

1 trial(s) available for beta-lactams and Infections, Legionella pneumophila

Article	Year
β-Lactam monotherapy vs β-lactam-macrolide combination treatment in moderately severe community-acquired pneumonia: a randomized noninferiority trial. JAMA internal medicine, 2014, Volume: 174, Issue:12 Topics: Aged; Aged, 80 and over; Anti-Bacterial Agents; beta-Lactams; Community-Acquired Infections; Drug Therapy, Combination; Follow-Up Studies; Hospitalization; Humans; Legionella pneumophila; Legionnaires' Disease; Macrolides; Middle Aged; Odds Ratio; Pneumonia, Bacterial; Severity of Illness Index; Switzerland; Treatment Outcome	2014

Article

Year

β-Lactam monotherapy vs β-lactam-macrolide combination treatment in moderately severe community-acquired pneumonia: a randomized noninferiority trial.

JAMA internal medicine, 2014, Volume: 174, Issue:12

Topics: Aged; Aged, 80 and over; Anti-Bacterial Agents; beta-Lactams; Community-Acquired Infections; Drug Therapy, Combination; Follow-Up Studies; Hospitalization; Humans; Legionella pneumophila; Legionnaires' Disease; Macrolides; Middle Aged; Odds Ratio; Pneumonia, Bacterial; Severity of Illness Index; Switzerland; Treatment Outcome

2014

Other Studies

8 other study(ies) available for beta-lactams and Infections, Legionella pneumophila

Article	Year
Early discontinuation of combination antibiotic therapy in severe community-acquired pneumonia: a retrospective cohort study. BMC infectious diseases, 2023, Sep-18, Volume: 23, Issue:1 Topics: Anti-Bacterial Agents; Antigens, Bacterial; beta-Lactams; Community-Acquired Infections; Humans; Influenza, Human; Lactams; Legionnaires' Disease; Pneumonia, Mycoplasma; Quinolones; Retrospective Studies	2023
Coverage of atypical pathogens for hospitalised patients with community-acquired pneumonia is not guided by clinical parameters. Swiss medical weekly, 2013, Volume: 143 Topics: Adult; Age Factors; Aged; Anti-Bacterial Agents; beta-Lactams; Chlamydial Pneumonia; Clarithromycin; Community-Acquired Infections; Drug Therapy, Combination; Guideline Adherence; Hospitalization; Humans; Immunocompromised Host; Legionnaires' Disease; Macrolides; Male; Middle Aged; Odds Ratio; Pneumonia, Bacterial; Pneumonia, Mycoplasma; Pneumonia, Pneumococcal; Practice Guidelines as Topic; Practice Patterns, Physicians'; Retrospective Studies; Severity of Illness Index	2013
The debate on antibiotic therapy for patients hospitalized for pneumonia: where should we go from here? JAMA internal medicine, 2014, Volume: 174, Issue:12 Topics: Anti-Bacterial Agents; beta-Lactams; Humans; Legionnaires' Disease; Macrolides; Pneumonia, Bacterial	2014
Empirical Therapy of Community-Acquired Pneumonia: Advancing Evidence or Just More Doubt? JAMA, 2015, Jul-28, Volume: 314, Issue:4 Topics: Anti-Bacterial Agents; beta-Lactams; Humans; Legionnaires' Disease; Macrolides; Pneumonia, Bacterial	2015
The science of selecting antimicrobials for community-acquired pneumonia (CAP). Journal of managed care pharmacy : JMCP, 2009, Volume: 15, Issue:2 Suppl Topics: Anti-Bacterial Agents; beta-Lactams; Chlamydophila pneumoniae; Community-Acquired Infections; Drug Resistance, Bacterial; Drug Therapy, Combination; Fluoroquinolones; Humans; Legionnaires' Disease; Macrolides; Microbial Sensitivity Tests; Pneumonia, Bacterial; Practice Guidelines as Topic; Streptococcus pneumoniae	2009
Empyema caused by Legionella pneumophila. Archivos de bronconeumologia, 2012, Volume: 48, Issue:3 Topics: Acute-Phase Proteins; Aged; Antigens, Bacterial; beta-Lactams; Body Fluids; Cough; Drug Therapy, Combination; Dyspnea; Empyema, Pleural; Humans; Legionella pneumophila; Legionnaires' Disease; Male; Ofloxacin; Tomography, X-Ray Computed	2012
Impact of positive legionella urinary antigen test on patient management and improvement of antibiotic use. Journal of clinical pathology, 2004, Volume: 57, Issue:12 Topics: Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Antigens, Bacterial; beta-Lactams; Carbapenems; Cephalosporins; Child, Preschool; Female; Humans; Immunoenzyme Techniques; Legionnaires' Disease; Macrolides; Male; Middle Aged; Retrospective Studies; Sensitivity and Specificity	2004
Inactivation of beta-lactam antibiotics by Legionella pneumophila. Antimicrobial agents and chemotherapy, 1979, Volume: 16, Issue:5 Topics: Anti-Bacterial Agents; beta-Lactamases; beta-Lactams; Drug Resistance, Microbial; Legionnaires' Disease; Microbial Sensitivity Tests; Substrate Specificity; Time Factors	1979